Dimensional Fund Advisors’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-232
| Closed | -$69.5K | – | 3391 |
|
|
2024
Q1 | $69.5K | Buy |
+232
| New | +$69.3K | ﹤0.01% | 3303 |
|
|
2023
Q4 | – | Sell |
-445
| Closed | -$66.8K | – | 3432 |
|
|
2023
Q3 | $66.8K | Hold |
445
| – | – | ﹤0.01% | 3359 |
|
|
2023
Q2 | $77.5K | Sell |
445
-223
| -33% | -$37.4K | ﹤0.01% | 3361 |
|
|
2023
Q1 | $84.1K | Sell |
668
-75
| -10% | -$16.9K | ﹤0.01% | 3326 |
|
|
2022
Q4 | $225 | Buy |
+743
| New | +$110K | ﹤0.01% | 3204 |
|
|
2022
Q2 | – | Sell |
-2,711
| Closed | -$309K | – | 3492 |
|
|
2022
Q1 | $309K | Sell |
2,711
-2,933
| -52% | -$344K | ﹤0.01% | 3243 |
|
|
2021
Q4 | $813K | Sell |
5,644
-3,402
| -38% | -$617K | ﹤0.01% | 3073 |
|
|
2021
Q3 | $1.98M | Sell |
9,046
-2,743
| -23% | -$581K | ﹤0.01% | 2857 |
|
|
2021
Q2 | $2.73M | Sell |
11,789
-357
| -3% | -$90.9K | ﹤0.01% | 2792 |
|
|
2021
Q1 | $3.66M | Buy |
12,146
+65
| +0.5% | +$23.3K | ﹤0.01% | 2676 |
|
|
2020
Q4 | $4.54M | Buy |
12,081
+112
| +0.9% | +$39.2K | ﹤0.01% | 2555 |
|
|
2020
Q3 | $3.67M | Buy |
11,969
+188
| +2% | +$71.9K | ﹤0.01% | 2552 |
|
|
2020
Q2 | $4.43M | Buy |
11,781
+28
| +0.2% | +$7.93K | ﹤0.01% | 2517 |
|
|
2020
Q1 | $2.68M | Buy |
11,753
+1,263
| +12% | +$483K | ﹤0.01% | 2614 |
|
|
2019
Q4 | $5.55M | Buy |
10,490
+93
| +0.9% | +$50.3K | ﹤0.01% | 2578 |
|
|
2019
Q3 | $4.48M | Buy |
10,397
+524
| +5% | +$337K | ﹤0.01% | 2638 |
|
|
2019
Q2 | $11.8M | Buy |
9,873
+1,203
| +14% | +$1.44M | ﹤0.01% | 2332 |
|
|
2019
Q1 | $10.8M | Buy |
8,670
+2,496
| +40% | +$2.86M | ﹤0.01% | 2375 |
|
|
2018
Q4 | $5.85M | Buy |
6,174
+2,286
| +59% | +$2.75M | ﹤0.01% | 2554 |
|
|
2018
Q3 | $5.6M | Buy |
+3,888
| New | +$5.88M | ﹤0.01% | 2644 |
|
Other funds holding CBIO
BI
AG
